UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
October 01, 2013
September 27, 2013
A consortium of the five University of California medical campuses, including UCSF, has been awarded a $12 million grant and designated by the National Institutes of Health as one of three Centers for Accelerated Innovations by the National Heart, Lung and Blood Institute.
July 03, 2013
The ability to form blood vessels is one of evolution’s crowning achievements. Now, scientists at the Gladstone Institutes have identified the molecular signals that direct the process of committing endothelial cells to become arteries or veins during embryonic development.
June 05, 2013
A new UCSF study finds that poor sleep – particularly waking too early – appears to play a significant role in raising unhealthy levels of inflammation among women with coronary heart disease.
April 11, 2013
A common test that records the heart’s electrical activity could predict potentially serious cardiovascular illness, according to a UC San Francisco-led study.
March 19, 2013
A UCSF team has developed an ambitious online cardiovascular study using smartphones, with the goal of enrolling 1 million people from all over the world to improve heart health.
February 13, 2013
Giving chocolates on Valentine's Day is a billion-dollar business in the United States, but besides delighting our taste buds, dark chocolate actually has health benefits for the body, a UCSF cardiologist says.
February 11, 2013
A new study finds that hundreds of thousands of lives could be saved over 10 years if Americans reduced their sodium consumption to the levels recommended in federal guidelines.
January 17, 2013
The risk of kidney failure is greater for people with chronic kidney disease who also have atrial fibrillation, one of the most common forms of irregular heart rhythm in adults, according to a new study by researchers at UCSF and the Kaiser Permanente Northern California Division of Research.
November 06, 2012
Hospitalized heart failure patients who received the drug, serelaxin, in a phase III clinical trial had fewer disease symptoms and as a group experienced 37 percent fewer deaths over six months, according to results of a new study.